Related references
Note: Only part of the references are listed.Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing
Wenbiao Chen et al.
PATHOLOGY & ONCOLOGY RESEARCH (2022)
Metabolic Syndrome Pathophysiology and Predisposing Factors
Antonio Bovolini et al.
INTERNATIONAL JOURNAL OF SPORTS MEDICINE (2021)
Adipose tissue inflammation and metabolic dysfunction in obesity
Tatsuo Kawai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)
CRISPR/Cas9-mediated knockout of APOC3 stabilizes plasma lipids and inhibits atherosclerosis in rabbits
Yiwen Zha et al.
LIPIDS IN HEALTH AND DISEASE (2021)
NLRP3 inflammasome in cancer and metabolic diseases
Bhesh Raj Sharma et al.
NATURE IMMUNOLOGY (2021)
Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment
Margarita Neganova et al.
CANCERS (2021)
Single-Cell Sequencing of Hepatocellular Carcinoma Reveals Cell Interactions and Cell Heterogeneity in the Microenvironment
Xinyao Li et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells
Xiangyu Hu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases
Siwen Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
High Expression of Angiopoietin-like Protein 4 in Advanced Colorectal Cancer and its Association with Regulatory T Cells and M2 Macrophages
Shuaiyang Zhou et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
Stephen Zewinger et al.
NATURE IMMUNOLOGY (2020)
APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis
Mingjiong Tong et al.
IUBMB LIFE (2020)
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Marja-Riitta Taskinen et al.
CURRENT ATHEROSCLEROSIS REPORTS (2019)
Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice
Yue Zhang et al.
CELL DEATH & DISEASE (2019)
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling
Takuji Hayashi et al.
CLINICAL CANCER RESEARCH (2018)
APOC-III Antisense Oligonucleotides: A New Option for the Treatment of Hypertriglyceridemia
Joel Schmitz et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Higher body mass index is associated with better survival in patients with myelodysplastic syndromes
Kausar J. Jabbar et al.
LEUKEMIA RESEARCH (2018)
The regulation of FOXO1 and its role in disease progression
Ya-qi Xing et al.
LIFE SCIENCES (2018)
mTOR signalling and cellular metabolism are mutual determinants in cancer
Dirk Mossmann et al.
NATURE REVIEWS CANCER (2018)
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
Sumeet A. Khetarpal et al.
NATURE MEDICINE (2017)
Development of a novel model of hypertriglyceridemic acute pancreatitis in mice
Yiyuan Pan et al.
SCIENTIFIC REPORTS (2017)
Obesity and cancer: inflammation bridges the two
Ryan Kolb et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
The phospholipase A2 activity of peroxiredoxin 6 modulates NADPH oxidase 2 activation via lysophosphatidic acid receptor signaling in the pulmonary endothelium and alveolar macrophages
Jose Pablo Vazquez-Medina et al.
FASEB JOURNAL (2016)
Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice
Yun-Zi Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The Obesity Paradox in Cancer: a Review
Hannah Lennon et al.
CURRENT ONCOLOGY REPORTS (2016)
Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis
Yongyan Song et al.
LIPIDS IN HEALTH AND DISEASE (2015)
The Tyrosine Kinase Syk Differentially Regulates Toll-like Receptor Signaling Downstream of the Adaptor Molecules TRAF6 and TRAF3
Ying-Cing Lin et al.
SCIENCE SIGNALING (2013)
Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample
Rebecca L. Pollex et al.
BMC MEDICAL GENETICS (2007)
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide
Mi Sun Jin et al.
CELL (2007)
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran
Ho Min Kim et al.
CELL (2007)
Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice
Shen Qu et al.
JOURNAL OF LIPID RESEARCH (2007)
APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome
Michael Miller et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes
William E. Alborn et al.
CLINICA CHIMICA ACTA (2007)
Structure and function of Toll-like receptor proteins
TK Means et al.
LIFE SCIENCES (2000)